medicines which might be substrates with the CYP3A enzyme as they may grow to be significantly less helpful through treatment with JOURNAVX. Your Health care service provider might have to adjust the dose of one's drugs when commencing or stopping JOURNAVXThis structural difference has led scientists to discover alternate pathways for its outcomes.